A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
Clinical trial NCT05702034 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05702034
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-15
- Primary completion
- 2026-11-11
- Enrollment
- 12532
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.